The afternoon Track 2 (Genomic Medicine) sessions of the final day of the Precision Medicine World Conference (PMWC) 2018 began with a talk by Lisa Alderson, Co-Founder and CEO, Genome Medical, that was titled “Harnessing Genetic Insights to Improve Patient Care.” Ms. Alderson had previously served as CSO at Invitae and as CEO and President of CrossLoop, Inc. She had also been the manager of Strategic Planning at Walt Disney, Co. The other co-founders of Genome Medical are Randy Scott, former CEO, Invitae; and Dr. Robert Green, Professor of Medicine, Harvard Medical School, and Director of the Genomes2People Research Program. Ms. Alderson opened her talk by posing the question—how do you tap the health-improving potential of the 325 million genomes in the US, with only about 6,000 genetic experts to rely on? She said that Genome Medical is the country’s first nationwide genomics practice. By offering easy access to clinical genetics experts through a digital health platform, Genome Medical is accelerating the integration of genomics into everyday health care. According to its web site, Genome Medical was founded to bridge the growing gap between available genome technology and current medical practice. In an age of incredible medical achievements and the advancement of DNA sequencing, many physicians, patients, and healthy individuals lack access to the advantages of genetic testing. Genome Medical exists to improve the logistics of ordering pertinent genetic tests and combine them with the appropriate genetic counseling for the benefit of individuals and their families. Each person’s unique genome significantly impacts health, severity of disease, and response to therapy. The genome isn’t responsible for all disease, but it is connected to virtually every aspect of well-being throughout a lifetime and across many conditions.
Login Or Register To Read Full Story